|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q61046798
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000329.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q61046798
|
|
024
|
|
|
‡a
0000-0002-0652-6834
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q61046798
|
|
046
|
|
|
‡f
19470729
|
|
100
|
0 |
|
‡a
Larry J. Anderson
‡c
American virologist
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Larry J. Anderson
‡c
viroloog
‡9
nl
|
|
400
|
0 |
|
‡a
ল্যারি জে অ্যান্ডারসন
‡9
bn
|
|
400
|
0 |
|
‡a
Larry J. Anderson
‡c
virólogo estadounidense
‡9
es
|
|
670
|
|
|
‡a
Author's 2314. Burden of Respiratory Syncytial Virus (RSV) Infection Among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)
|
|
670
|
|
|
‡a
Author's A Built-In CpG Adjuvant in RSV F Protein DNA Vaccine Drives a Th1 Polarized and Enhanced Protective Immune Response.
|
|
670
|
|
|
‡a
Author's A cohort study of health care workers to assess nosocomial transmissibility of Nipah virus, Malaysia, 1999.
|
|
670
|
|
|
‡a
Author's A distinct lineage of influenza A virus from bats
|
|
670
|
|
|
‡a
Author's A large outbreak of epidemic keratoconjunctivitis: problems in controlling nosocomial spread
|
|
670
|
|
|
‡a
Author's A novel coronavirus associated with severe acute respiratory syndrome
|
|
670
|
|
|
‡a
Author's A passive quantitative measurement of airway resistance using depth data
|
|
670
|
|
|
‡a
Author's A respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's A respiratory syncytial virus attachment (G) gene variant associated with more severe disease in infants decreases fusion (F) protein expression which may facilitate immune evasion
|
|
670
|
|
|
‡a
Author's A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice
|
|
670
|
|
|
‡a
Author's A Vision-Based Respiration Monitoring System for Passive Airway Resistance Estimation
|
|
670
|
|
|
‡a
Author's Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation.
|
|
670
|
|
|
‡a
Author's Acute hemorrhagic conjunctivitis due to enterovirus 70 in American Samoa: serum-neutralizing antibodies and sex-specific protection
|
|
670
|
|
|
‡a
Author's Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D
|
|
670
|
|
|
‡a
Author's Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47)
|
|
670
|
|
|
‡a
Author's An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice
|
|
670
|
|
|
‡a
Author's An epidemic of acute hemorrhagic conjunctivitis in American Samoa caused by coxsackievirus A24 variant
|
|
670
|
|
|
‡a
Author's Analysis of antigenically intermediate strains of subgenus B and D adenoviruses from AIDS patients
|
|
670
|
|
|
‡a
Author's Analysis of respiratory syncytial virus genetic variability with amplified cDNAs
|
|
670
|
|
|
‡a
Author's Annual variation in respiratory syncytial virus season and decisions regarding immunoprophylaxis with palivizumab
|
|
670
|
|
|
‡a
Author's Anti-respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model.
|
|
670
|
|
|
‡a
Author's Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line
|
|
670
|
|
|
‡a
Author's Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines.
|
|
670
|
|
|
‡a
Author's Antigenic analysis of current wild type and vaccine strains of measles virus
|
|
670
|
|
|
‡a
Author's Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children
|
|
670
|
|
|
‡a
Author's Antigenic and genomic diversity within group A respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Antigenic and nucleic acid analysis of nosocomial isolates of respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Antigenic characterization of respiratory syncytial virus group A and B isolates in Rio de Janeiro, Brazil.
|
|
670
|
|
|
‡a
Author's Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies
|
|
670
|
|
|
‡a
Author's Aplastic crisis in sickle cell disorders: bone marrow necrosis and human parvovirus infection
|
|
670
|
|
|
‡a
Author's Application of proteomics methods for pathogen discovery
|
|
670
|
|
|
‡a
Author's Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens
|
|
670
|
|
|
‡a
Author's Aqueous Quaternary Ammonium Compounds and Rabies Treatment
|
|
670
|
|
|
‡a
Author's Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children
|
|
670
|
|
|
‡a
Author's Beyond viruses: clinical profiles and etiologies associated with encephalitis
|
|
670
|
|
|
‡a
Author's Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development
|
|
670
|
|
|
‡a
Author's Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway
|
|
670
|
|
|
‡a
Author's Broadly reactive pan-paramyxovirus reverse transcription polymerase chain reaction and sequence analysis for the detection of Canine distemper virus in a case of canine meningoencephalitis of unknown etiology
|
|
670
|
|
|
‡a
Author's Bronchiolitis-associated hospitalizations among American Indian and Alaska Native children
|
|
670
|
|
|
‡a
Author's Bronchiolitis-associated hospitalizations among US children, 1980-1996.
|
|
670
|
|
|
‡a
Author's Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.
|
|
670
|
|
|
‡a
Author's Burden of encephalitis-associated hospitalizations in the United States, 1988-1997.
|
|
670
|
|
|
‡a
Author's Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia
|
|
670
|
|
|
‡a
Author's CD4(+) T cell frequencies and Th1/Th2 cytokine patterns expressed in the acute and memory response to respiratory syncytial virus I-E(d)-restricted peptides.
|
|
670
|
|
|
‡a
Author's CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse
|
|
670
|
|
|
‡a
Author's CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice
|
|
670
|
|
|
‡a
Author's Challenges and opportunities for respiratory syncytial virus vaccines
|
|
670
|
|
|
‡a
Author's Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop
|
|
670
|
|
|
‡a
Author's Challenges to evaluating respiratory syncytial virus mortality in Bangladesh, 2004-2008.
|
|
670
|
|
|
‡a
Author's Characterization of a novel coronavirus associated with severe acute respiratory syndrome
|
|
670
|
|
|
‡a
Author's Characterization of human metapneumoviruses isolated from patients in North America
|
|
670
|
|
|
‡a
Author's Chemiluminescent microwell hybridization assay for direct detection of human parvovirus B19 DNA
|
|
670
|
|
|
‡a
Author's Chronic parvovirus infection in a presumably immunologically healthy woman
|
|
670
|
|
|
‡a
Author's Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community
|
|
670
|
|
|
‡a
Author's Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America
|
|
670
|
|
|
‡a
Author's Clinical and epidemiologic features of respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Clinical patterns and seasonal trends in respiratory syncytial virus hospitalizations in São Paulo, Brazil.
|
|
670
|
|
|
‡a
Author's Combination therapy using monoclonal antibodies against respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice
|
|
670
|
|
|
‡a
Author's Community outbreak of thyrotoxicosis: epidemiology, immunogenetic characteristics, and long-term outcome
|
|
670
|
|
|
‡a
Author's Comparative detection of measles-specific IgM in oral fluid and serum from children by an antibody-capture IgM EIA.
|
|
670
|
|
|
‡a
Author's Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine
|
|
670
|
|
|
‡a
Author's Comparison of a monoclonal antibody with a polyclonal serum in an enzyme-linked immunosorbent assay for detecting adenovirus.
|
|
670
|
|
|
‡a
Author's Comparison of monoclonal antibody time-resolved fluoroimmunoassay with monoclonal antibody capture-biotinylated detector enzyme immunoassay for respiratory syncytial virus and parainfluenza virus antigen detection
|
|
670
|
|
|
‡a
Author's Comparison of monoclonal time-resolved fluoroimmunoassay with monoclonal capture-biotinylated detector enzyme immunoassay for adenovirus antigen detection
|
|
670
|
|
|
‡a
Author's Complications of smallpox vaccination in Kentucky in 1968. Results of a statewide survey
|
|
670
|
|
|
‡a
Author's Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks
|
|
670
|
|
|
‡a
Author's Coronavirus antibodies in bat biologists
|
|
670
|
|
|
‡a
Author's Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team
|
|
670
|
|
|
‡a
Author's Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human
|
|
670
|
|
|
‡a
Author's CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
|
|
670
|
|
|
‡a
Author's CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.
|
|
670
|
|
|
‡a
Author's Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells
|
|
670
|
|
|
‡a
Author's Cytotoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin-inactivated RSV vaccine
|
|
670
|
|
|
‡a
Author's Day-care center attendance and hospitalization for lower respiratory tract illness
|
|
670
|
|
|
‡a
Author's Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group
|
|
670
|
|
|
‡a
Author's Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice
|
|
670
|
|
|
‡a
Author's Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay
|
|
670
|
|
|
‡a
Author's Detection of enterovirus 70 with monoclonal antibodies
|
|
670
|
|
|
‡a
Author's Detection of Norwalk virus antibodies and antigen with a biotin-avidin immunoassay
|
|
670
|
|
|
‡a
Author's Detection of novel SARS-like and other coronaviruses in bats from Kenya
|
|
670
|
|
|
‡a
Author's Detection of RSV Antibodies in Human Plasma by Enzyme Immunoassays
|
|
670
|
|
|
‡a
Author's Development and evaluation of an IgM capture enzyme immunoassay for diagnosis of recent Norwalk virus infection
|
|
670
|
|
|
‡a
Author's Development and optimization of a Zika virus antibody-dependent cell-mediated cytotoxicity (ADCC) assay
|
|
670
|
|
|
‡a
Author's Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43
|
|
670
|
|
|
‡a
Author's Diagnosis of enterovirus 70 infection by demonstration of IgM antibodies
|
|
670
|
|
|
‡a
Author's Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset
|
|
670
|
|
|
‡a
Author's Diarrheal deaths in American children. Are they preventable?
|
|
670
|
|
|
‡a
Author's Diarrheal illness among infants and toddlers in day care centers: effects of active surveillance and staff training without subsequent monitoring
|
|
670
|
|
|
‡a
Author's Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy
|
|
670
|
|
|
‡a
Author's Differentiation of respiratory syncytial virus subgroups with cDNA probes in a nucleic acid hybridization assay
|
|
670
|
|
|
‡a
Author's Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation
|
|
670
|
|
|
‡a
Author's Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center.
|
|
670
|
|
|
‡a
Author's Eighteen Years of Respiratory Syncytial Virus Surveillance: Changes in Seasonality and Hospitalization Rates in Southwestern Alaska Native Children.
|
|
670
|
|
|
‡a
Author's Emerging human coronaviruses--disease potential and preparedness
|
|
670
|
|
|
‡a
Author's Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P
|
|
670
|
|
|
‡a
Author's Enterovirus 71 infections and neurologic disease--United States, 1977-1991
|
|
670
|
|
|
‡a
Author's Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005.
|
|
670
|
|
|
‡a
Author's Epidemic infections caused by respiratory syncytial virus in institutionalized young adults
|
|
670
|
|
|
‡a
Author's Epidemiology and prevention of respiratory syncytial virus infections among infants and young children
|
|
670
|
|
|
‡a
Author's Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus.
|
|
670
|
|
|
‡a
Author's Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infection
|
|
670
|
|
|
‡a
Author's Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities
|
|
670
|
|
|
‡a
Author's GeneScan reverse transcription-PCR assay for detection of six common respiratory viruses in young children hospitalized with acute respiratory illness
|
|
670
|
|
|
‡a
Author's Genetic diversity of human parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates
|
|
670
|
|
|
‡a
Author's Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses
|
|
670
|
|
|
‡a
Author's Genetic heterogeneity of the attachment glycoprotein G among group A respiratory syncytial viruses
|
|
670
|
|
|
‡a
Author's Genetic variability in envelope-associated protein genes of closely related group A strains of respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Genetic variability of group A and B human respiratory syncytial viruses isolated from 3 provinces in China
|
|
670
|
|
|
‡a
Author's Genomic characterization of seven distinct bat coronaviruses in Kenya
|
|
670
|
|
|
‡a
Author's Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections
|
|
670
|
|
|
‡a
Author's Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.
|
|
670
|
|
|
‡a
Author's Health care transmission of a newly emergent adenovirus serotype in health care personnel at a military hospital in Texas, 2007.
|
|
670
|
|
|
‡a
Author's Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.
|
|
670
|
|
|
‡a
Author's Human bocavirus: a new viral pathogen
|
|
670
|
|
|
‡a
Author's Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand
|
|
670
|
|
|
‡a
Author's Human metapneumovirus infection among children hospitalized with acute respiratory illness
|
|
670
|
|
|
‡a
Author's Human metapneumovirus infections in young and elderly adults.
|
|
670
|
|
|
‡a
Author's Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States
|
|
670
|
|
|
‡a
Author's Human parvovirus B19
|
|
670
|
|
|
‡a
Author's Human parvovirus B19 and pregnancy.
|
|
670
|
|
|
‡a
Author's Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia
|
|
670
|
|
|
‡a
Author's Human parvovirus B19 infection during pregnancy
|
|
670
|
|
|
‡a
Author's Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum
|
|
670
|
|
|
‡a
Author's Human parvoviruses
|
|
670
|
|
|
‡a
Author's Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention
|
|
670
|
|
|
‡a
Author's Human rhinovirus induced cytokine/chemokine responses in human airway epithelial and immune cells
|
|
670
|
|
|
‡a
Author's Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children
|
|
670
|
|
|
‡a
Author's Human-to-Human Transmission of Rabies Virus by Corneal Transplant
|
|
670
|
|
|
‡a
Author's Identification of a novel astrovirus
|
|
670
|
|
|
‡a
Author's Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis
|
|
670
|
|
|
‡a
Author's Identification of adenoviruses in fecal specimens from wild chimpanzees (Pan trogylodytes schweinfurthii) in western Tanzania
|
|
670
|
|
|
‡a
Author's Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay
|
|
670
|
|
|
‡a
Author's Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments
|
|
670
|
|
|
‡a
Author's Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines
|
|
670
|
|
|
‡a
Author's Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming
|
|
670
|
|
|
‡a
Author's Immunochemiluminescent Southern blot assay for polymerase chain reaction detection of human parvovirus B19 DNA
|
|
670
|
|
|
‡a
Author's In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000.
|
|
670
|
|
|
‡a
Author's In vitro model for the assessment of human immune responses to subunit RSV vaccines
|
|
670
|
|
|
‡a
Author's Induction of cytokine mRNA in peripheral blood mononuclear cells of infants after the first dose of measles vaccine
|
|
670
|
|
|
‡a
Author's Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze
|
|
670
|
|
|
‡a
Author's Infectious disease hospitalizations among American Indian and Alaska native infants
|
|
670
|
|
|
‡a
Author's Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy.
|
|
670
|
|
|
‡a
Author's Investigation of porcine parvovirus among persons with hemophilia receiving Hyate:C porcine factor VIII concentrate
|
|
670
|
|
|
‡a
Author's Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Kawasaki disease and human coronavirus
|
|
670
|
|
|
‡a
Author's Kawasaki disease in a young adult
|
|
670
|
|
|
‡a
Author's Kawasaki Syndrome: Description of Two Outbreaks in the United States
|
|
670
|
|
|
‡a
Author's Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China
|
|
670
|
|
|
‡a
Author's Lower respiratory tract infections among american Indian and Alaska Native children and the general population of U.S. Children
|
|
670
|
|
|
‡a
Author's Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study
|
|
670
|
|
|
‡a
Author's Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay
|
|
670
|
|
|
‡a
Author's Minimally Invasive Sampling Method Identifies Differences in Taxonomic Richness of Nasal Microbiomes in Young Infants Associated with Mode of Delivery.
|
|
670
|
|
|
‡a
Author's Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward
|
|
670
|
|
|
‡a
Author's Molecular characterization of Nipah virus, a newly emergent paramyxovirus
|
|
670
|
|
|
‡a
Author's Molecular detection of adenoviruses, rhabdoviruses, and paramyxoviruses in bats from Kenya
|
|
670
|
|
|
‡a
Author's Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000
|
|
670
|
|
|
‡a
Author's Monoclonal antibodies for the rapid diagnosis of respiratory syncytial virus infection by immunofluorescence
|
|
670
|
|
|
‡a
Author's Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins
|
|
670
|
|
|
‡a
Author's Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Monoclonal capture antibody ELISA for respiratory syncytial virus: detection of individual viral antigens and determination of monoclonal antibody specificities
|
|
670
|
|
|
‡a
Author's Mortality associated with influenza and respiratory syncytial virus in the United States
|
|
670
|
|
|
‡a
Author's MUC5AC Levels Associated With Respiratory Syncytial Virus Disease Severity
|
|
670
|
|
|
‡a
Author's Multicenter study of strains of respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Multiple primer pairs for polymerase chain reaction
|
|
670
|
|
|
‡a
Author's Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA
|
|
670
|
|
|
‡a
Author's Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective
|
|
670
|
|
|
‡a
Author's Mutation of Respiratory Syncytial Virus G Protein's CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells
|
|
670
|
|
|
‡a
Author's Nanoparticle vaccines encompassing the respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease
|
|
670
|
|
|
‡a
Author's Nasopharyngeal Haemophilus and Local Immune Response during Infant Respiratory Syncytial Virus Infection
|
|
670
|
|
|
‡a
Author's Nasopharyngeal Lactobacillus is Associated with Childhood Wheezing Illnesses Following Acute Respiratory Syncytial Virus Infection in Infancy
|
|
670
|
|
|
‡a
Author's Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk
|
|
670
|
|
|
‡a
Author's National surveillance for respiratory syncytial virus, United States, 1985-1990.
|
|
670
|
|
|
‡a
Author's National surveillance of Kawasaki disease.
|
|
670
|
|
|
‡a
Author's Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies.
|
|
670
|
|
|
‡a
Author's Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection
|
|
670
|
|
|
‡a
Author's Nipah virus: a recently emergent deadly paramyxovirus
|
|
670
|
|
|
‡a
Author's Nonclassic measles infections in an immune population exposed to measles during a college bus trip
|
|
670
|
|
|
‡a
Author's Norwalk virus antigen and antibody response in an adult volunteer study
|
|
670
|
|
|
‡a
Author's Nosocomial transmission of respiratory syncytial virus in immunocompromised adults.
|
|
670
|
|
|
‡a
Author's Novel human rhinoviruses and exacerbation of asthma in children
|
|
670
|
|
|
‡a
Author's Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE).
|
|
670
|
|
|
‡a
Author's Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum
|
|
670
|
|
|
‡a
Author's Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children
|
|
670
|
|
|
‡a
Author's Outbreak of echovirus 11 infection in hospitalized neonates
|
|
670
|
|
|
‡a
Author's Outbreak of pneumonia associated with emergent human adenovirus serotype 14--Southeast Alaska, 2008
|
|
670
|
|
|
‡a
Author's Outbreak of pneumonia in a long-term care facility: antecedent human parainfluenza virus 1 infection may predispose to bacterial pneumonia
|
|
670
|
|
|
‡a
Author's Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007.
|
|
670
|
|
|
‡a
Author's Outpatient and hospital visits associated with otitis media among American Indian and Alaska native children younger than 5 years
|
|
670
|
|
|
‡a
Author's Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection
|
|
670
|
|
|
‡a
Author's Parvovirus B19 infection in hospital workers: community or hospital acquisition?
|
|
670
|
|
|
‡a
Author's Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophilia
|
|
670
|
|
|
‡a
Author's Pathologic Studies of Fatal Cases in Outbreak of Hand, Foot, and Mouth Disease, Taiwan
|
|
670
|
|
|
‡a
Author's Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Pediatric hospitalizations for croup
|
|
670
|
|
|
‡a
Author's Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics
|
|
670
|
|
|
‡a
Author's Performance evaluation of antibody tests for detecting infant respiratory syncytial virus infection
|
|
670
|
|
|
‡a
Author's Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA.
|
|
670
|
|
|
‡a
Author's Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study
|
|
670
|
|
|
‡a
Author's Pharyngoconjunctival Fever Caused by Adenovirus Type 4: Report of a Swimming Pool-Related Outbreak with Recovery of Virus from Pool Water
|
|
670
|
|
|
‡a
Author's Population biology, evolution, and immunology of vaccination and vaccination programs.
|
|
670
|
|
|
‡a
Author's Possible transmission of parvovirus B19 from intravenous immune globulin
|
|
670
|
|
|
‡a
Author's Postexposure trial of a human diploid cell strain rabies vaccine.
|
|
670
|
|
|
‡a
Author's Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.
|
|
670
|
|
|
‡a
Author's Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients.
|
|
670
|
|
|
‡a
Author's Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
|
|
670
|
|
|
‡a
Author's Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique
|
|
670
|
|
|
‡a
Author's Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection
|
|
670
|
|
|
‡a
Author's Prevalence of human parvovirus B19 infection in children with Henoch-Schönlein purpura
|
|
670
|
|
|
‡a
Author's Prevalence of viral respiratory tract infections in children with asthma.
|
|
670
|
|
|
‡a
Author's Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV.
|
|
670
|
|
|
‡a
Author's Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness.
|
|
670
|
|
|
‡a
Author's Progress in Vaccine-Preventable and Respiratory Infectious Diseases-First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006-2015
|
|
670
|
|
|
‡a
Author's Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice.
|
|
670
|
|
|
‡a
Author's Prophylaxis for persons in contact with patients who have rabies
|
|
670
|
|
|
‡a
Author's Prophylaxis with a respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice
|
|
670
|
|
|
‡a
Author's Protective and disease-enhancing immune responses to respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells
|
|
670
|
|
|
‡a
Author's Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles
|
|
670
|
|
|
‡a
Author's Quantification of respiratory syncytial virus polypeptides in nasal secretions by monoclonal antibodies
|
|
670
|
|
|
‡a
Author's Rabies diagnosis and rabies vaccine
|
|
670
|
|
|
‡a
Author's Rapid antibody response to human diploid rabies vaccine
|
|
670
|
|
|
‡a
Author's Rapid molecular epidemiologic studies of human parainfluenza viruses based on direct sequencing of amplified DNA from a multiplex RT-PCR assay
|
|
670
|
|
|
‡a
Author's Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes.
|
|
670
|
|
|
‡a
Author's Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus
|
|
670
|
|
|
‡a
Author's Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins
|
|
670
|
|
|
‡a
Author's Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
|
|
670
|
|
|
‡a
Author's Refractory status epilepticus in suspect encephalitis
|
|
670
|
|
|
‡a
Author's Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus and Staphylococcus aureus coinfection in children hospitalized with pneumonia
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice.
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus outbreak on American Samoa. Evaluation of risk factors
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus vaccine development
|
|
670
|
|
|
‡a
Author's Respiratory syncytial virus vaccines for otitis media
|
|
670
|
|
|
‡a
Author's Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene
|
|
670
|
|
|
‡a
Author's Response to rhinovirus infection by human airway epithelial cells and peripheral blood mononuclear cells in an in vitro two-chamber tissue culture system
|
|
670
|
|
|
‡a
Author's Rhinovirus-associated hospitalizations in young children
|
|
670
|
|
|
‡a
Author's Risk factors for bronchiolitis-associated deaths among infants in the United States
|
|
670
|
|
|
‡a
Author's Risk factors for Nipah virus infection among abattoir workers in Singapore
|
|
670
|
|
|
‡a
Author's Risk of adverse outcomes of pregnancy after human parvovirus B19 infection
|
|
670
|
|
|
‡a
Author's Risk of infection following exposures to human parvovirus B19
|
|
670
|
|
|
‡a
Author's Role of parvovirus B19 in human disease
|
|
670
|
|
|
‡a
Author's Rotavirus as a cause of diarrheal morbidity and mortality in the United States
|
|
670
|
|
|
‡a
Author's RSV Strains and Disease Severity
|
|
670
|
|
|
‡a
Author's SARS-associated coronavirus transmission, United States
|
|
670
|
|
|
‡a
Author's SARS-coronavirus replication in human peripheral monocytes/macrophages
|
|
670
|
|
|
‡a
Author's SARS preparedness and response planning
|
|
670
|
|
|
‡a
Author's SARS surveillance during emergency public health response, United States, March-July 2003.
|
|
670
|
|
|
‡a
Author's Seasonal Timing of Infant Bronchiolitis, Apnea and Sudden Unexplained Infant Death
|
|
670
|
|
|
‡a
Author's Seasonal trends of human parainfluenza viral infections: United States, 1990-2004.
|
|
670
|
|
|
‡a
Author's Secretory Expression and Purification of Respiratory Syncytial Virus G and F Proteins in Human Cells
|
|
670
|
|
|
‡a
Author's Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses
|
|
670
|
|
|
‡a
Author's Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains.
|
|
670
|
|
|
‡a
Author's Sequence polymorphism of the predicted human metapneumovirus G glycoprotein
|
|
670
|
|
|
‡a
Author's Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group
|
|
670
|
|
|
‡a
Author's Serum immunoglobulin A response to Norwalk virus infection
|
|
670
|
|
|
‡a
Author's Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections
|
|
670
|
|
|
‡a
Author's Severe acute respiratory syndrome coronavirus on hospital surfaces
|
|
670
|
|
|
‡a
Author's Severe acute respiratory syndrome in children
|
|
670
|
|
|
‡a
Author's Severe acute respiratory syndrome: review and lessons of the 2003 outbreak
|
|
670
|
|
|
‡a
Author's Severe anemia caused by human parvovirus in a leukemia patient on maintenance chemotherapy
|
|
670
|
|
|
‡a
Author's Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii
|
|
670
|
|
|
‡a
Author's Severe postvaccinia encephalitis with acute disseminated encephalomyelitis: recovery with early intravenous immunoglobulin, high-dose steroids, and vaccinia immunoglobulin
|
|
670
|
|
|
‡a
Author's Sex-specific association between prenatal life stress exposure and infant pro-inflammatory cytokine levels during acute respiratory infection
|
|
670
|
|
|
‡a
Author's Simultaneous detection and identification of human parainfluenza viruses 1, 2, and 3 from clinical samples by multiplex PCR
|
|
670
|
|
|
‡a
Author's Spectrophotometric quantitation of peroxidase-stained protein bands following gel electrophoresis and the western blot transfer technique with respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Strain-specific reverse transcriptase PCR assay: means to distinguish candidate vaccine from wild-type strains of respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Strategic priorities for respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Strategic priorities for respiratory syncytial virus (RSV) vaccine development
|
|
670
|
|
|
‡a
Author's Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection
|
|
670
|
|
|
‡a
Author's Substantial variability in community respiratory syncytial virus season timing
|
|
670
|
|
|
‡a
Author's Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983
|
|
670
|
|
|
‡a
Author's TH
|
|
670
|
|
|
‡a
Author's TH(1)- and TH(2)-TYPE cytokine expression by activated t lymphocytes from the lung and spleen during the inflammatory response to respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection
|
|
670
|
|
|
‡a
Author's The clinical spectrum of human parvovirus B19 infections
|
|
670
|
|
|
‡a
Author's The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice
|
|
670
|
|
|
‡a
Author's The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P.
|
|
670
|
|
|
‡a
Author's The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography
|
|
670
|
|
|
‡a
Author's The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).
|
|
670
|
|
|
‡a
Author's Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus
|
|
670
|
|
|
‡a
Author's Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice
|
|
670
|
|
|
‡a
Author's Treatment of respiratory syncytial virus infection with vitamin A: a randomized, placebo-controlled trial in Santiago, Chile
|
|
670
|
|
|
‡a
Author's Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice
|
|
670
|
|
|
‡a
Author's Trends in encephalitis-associated deaths in the United States
|
|
670
|
|
|
‡a
Author's Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002.
|
|
670
|
|
|
‡a
Author's Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus
|
|
670
|
|
|
‡a
Author's Two RSV Platforms for G, F, or G+F Proteins VLPs
|
|
670
|
|
|
‡a
Author's Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
|
|
670
|
|
|
‡a
Author's Update on SARS research and other possibly zoonotic coronaviruses
|
|
670
|
|
|
‡a
Author's Urine Club Cell 16-kDa Secretory Protein and Childhood Wheezing Illnesses After Lower Respiratory Tract Infections in Infancy.
|
|
670
|
|
|
‡a
Author's Urine Levels of γ-Aminobutyric Acid are Associated with the Severity of Respiratory Syncytial Virus Infection in Infancy
|
|
670
|
|
|
‡a
Author's Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application to parvovirus B19 serology
|
|
670
|
|
|
‡a
Author's Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis
|
|
670
|
|
|
‡a
Author's Use of the biotin-avidin system to study the specificity of antibodies against respiratory syncytial virus.
|
|
670
|
|
|
‡a
Author's Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing
|
|
670
|
|
|
‡a
Author's Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice
|
|
670
|
|
|
‡a
Author's Variation in timing of respiratory syncytial virus outbreaks: lessons from national surveillance
|
|
670
|
|
|
‡a
Author's Viral meningitis-associated hospitalizations in the United States, 1988-1999.
|
|
670
|
|
|
‡a
Author's Viral respiratory infections in hospitalized and community control children in Alaska
|
|
670
|
|
|
‡a
Author's Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups
|
|
670
|
|
|
‡a
Author's Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States
|
|
670
|
|
|
‡a
Author's Waterborne gastroenteritis due to the Norwalk agent: clinical and epidemiologic investigation
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NII|DA10662566
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NUKAT|n 2017087522
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000036642399
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NTA|168422417
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BNF|12569728
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/199800406
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/LC|n 96803379
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|035007524
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NLA|000036068201
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NLI|004417334
|
|
670
|
|
|
‡a
wikidata site links
‡u
https://en.wikipedia.org/wiki/Larry_J._Anderson
|
|
909
|
|
|
‡a
(orcid) 0000000206526834
‡9
1
|
|
919
|
|
|
‡a
builtincpgadjuvantinrsvfproteindnavaccinedrivesath1polarizedandenhancedprotectiveimmuneresponse
‡A
A Built-In CpG Adjuvant in RSV F Protein DNA Vaccine Drives a Th1 Polarized and Enhanced Protective Immune Response.
‡9
1
|
|
919
|
|
|
‡a
waterbornegastroenteritisduetothenorwalkagentclinicalandepidemiologicinvestigation
‡A
Waterborne gastroenteritis due to the Norwalk agent: clinical and epidemiologic investigation
‡9
1
|
|
919
|
|
|
‡a
vitaminatherapyforchildrenwithrespiratorysyncytialvirusinfectionamulticentertrialintheunitedstates
‡A
Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States
‡9
1
|
|
919
|
|
|
‡a
virologicalfeaturesandclinicalmanifestationsassociatedwithhumanmetapneumovirusanewparamyxovirusresponsibleforacuterespiratorytractinfectionsinallagegroups
‡A
Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups
‡9
1
|
|
919
|
|
|
‡a
viralrespiratoryinfectionsinhospitalizedandcommunitycontrolchildreninalaska
‡A
Viral respiratory infections in hospitalized and community control children in Alaska
‡9
1
|
|
919
|
|
|
‡a
viralmeningitisassociatedhospitalizationsintheunitedstates1988
‡A
Viral meningitis-associated hospitalizations in the United States, 1988-1999.
‡9
1
|
|
919
|
|
|
‡a
variationintimingofrespiratorysyncytialvirusoutbreakslessonsfromnationalsurveillance
‡A
Variation in timing of respiratory syncytial virus outbreaks: lessons from national surveillance
‡9
1
|
|
919
|
|
|
‡a
vaccinationtoinduceantibodiesblockingthecx3ccx3cr1interactionofrespiratorysyncytialvirusgproteinreducespulmonaryinflammationandvirusreplicationinmice
‡A
Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice
‡9
1
|
|
919
|
|
|
‡a
usingurinemetabolomicstounderstandthepathogenesisofinfantrespiratorysyncytialvirusrsvinfectionanditsroleinchildhoodwheezing
‡A
Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing
‡9
1
|
|
919
|
|
|
‡a
useofthebiotinavidinsystemtostudythespecificityofantibodiesagainstrespiratorysyncytialvirus
‡A
Use of the biotin-avidin system to study the specificity of antibodies against respiratory syncytial virus.
‡9
1
|
|
919
|
|
|
‡a
useofrespiratorysyncytialvirussurveillancedatatooptimizethetimingofimmunoprophylaxis
‡A
Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis
‡9
1
|
|
919
|
|
|
‡a
useofmixturemodelsindetermininglaboratorycriterionforidentificationofseropositiveindividualsapplicationtoparvovirusb19serology
‡A
Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application to parvovirus B19 serology
‡9
1
|
|
919
|
|
|
‡a
urinelevelsofγaminobutyricacidareassociatedwiththeseverityofrespiratorysyncytialvirusinfectionininfancy
‡A
Urine Levels of γ-Aminobutyric Acid are Associated with the Severity of Respiratory Syncytial Virus Infection in Infancy
‡9
1
|
|
919
|
|
|
‡a
urineclubcell16kdasecretoryproteinandchildhoodwheezingillnessesafterlowerrespiratorytractinfectionsininfancy
‡A
Urine Club Cell 16-kDa Secretory Protein and Childhood Wheezing Illnesses After Lower Respiratory Tract Infections in Infancy.
‡9
1
|
|
919
|
|
|
‡a
updateonsarsresearchandotherpossiblyzoonoticcoronaviruses
‡A
Update on SARS research and other possibly zoonotic coronaviruses
‡9
1
|
|
919
|
|
|
‡a
type1andtype3ifnrestrictsarscov2infectionofhumanairwayepithelialcultures
‡A
Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
‡9
1
|
|
919
|
|
|
‡a
2rsvplatformsforgforg+fproteinsvlps
‡A
Two RSV Platforms for G, F, or G+F Proteins VLPs
‡9
1
|
|
919
|
|
|
‡a
2outbreaksofsevererespiratorydiseaseinnursinghomesassociatedwithrhinovirus
‡A
Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus
‡9
1
|
|
919
|
|
|
‡a
trendsinhospitalizationsforpneumoniaamongpersonsaged65yearsorolderintheunitedstates1988
‡A
Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002.
‡9
1
|
|
919
|
|
|
‡a
trendsinencephalitisassociateddeathsintheunitedstates
‡A
Trends in encephalitis-associated deaths in the United States
‡9
1
|
|
919
|
|
|
‡a
treatmentwithrespiratorysyncytialvirusgglycoproteinmonoclonalantibodyorfab2componentsmediatesreducedpulmonaryinflammationinmice
‡A
Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice
‡9
1
|
|
919
|
|
|
‡a
treatmentofrespiratorysyncytialvirusinfectionwithvitaminaarandomizedplacebocontrolledtrialinsantiagochile
‡A
Treatment of respiratory syncytial virus infection with vitamin A: a randomized, placebo-controlled trial in Santiago, Chile
‡9
1
|
|
919
|
|
|
‡a
therapeuticmonoclonalantibodytreatmenttargetingrespiratorysyncytialvirusrsvgproteinmediatesviralclearanceandreducesthepathogenesisofrsvinfectioninbalb100mice
‡A
Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice
‡9
1
|
|
919
|
|
|
‡a
therapeuticmonoclonalantibodytreatmenttargetingrespiratorysyncytialvirus
‡A
Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
roleofparvovirusb19inaplasticcrisisanderythemainfectiosum5disease
‡A
The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).
‡9
1
|
|
919
|
|
|
‡a
morphologyandassemblyofrespiratorysyncytialvirusrevealedbycryoelectrontomography
‡A
The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography
‡9
1
|
|
919
|
|
|
‡a
gglycoproteinofrespiratorysyncytialvirusdepressesrespiratoryratesthroughthecx3cmotifandsubstancep
‡A
The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P.
‡9
1
|
|
919
|
|
|
‡a
failureofinterleukin10deficientmicetodevelopairwayhyperresponsivenessisovercomebyrespiratorysyncytialvirusinfectioninallergensensitizedchallengedmice
‡A
The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice
‡9
1
|
|
919
|
|
|
‡a
clinicalspectrumofhumanparvovirusb19infections
‡A
The clinical spectrum of human parvovirus B19 infections
‡9
1
|
|
919
|
|
|
‡a
centralconservedregionccrofrespiratorysyncytialvirusrsvgproteinmodulateshostmirnaexpressionandaltersthecellularresponsetoinfection
‡A
The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection
‡9
1
|
|
919
|
|
|
‡a
th1andth2typecytokineexpressionbyactivatedtlymphocytesfromthelungandspleenduringtheinflammatoryresponsetorespiratorysyncytialvirus
‡A
TH(1)- and TH(2)-TYPE cytokine expression by activated t lymphocytes from the lung and spleen during the inflammatory response to respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
th
‡A
TH
‡9
1
|
|
919
|
|
|
‡a
temporalandgeographicpatternsofisolatesofnonpolioenterovirusintheunitedstates1970
‡A
Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983
‡9
1
|
|
919
|
|
|
‡a
substantialvariabilityincommunityrespiratorysyncytialvirusseasontiming
‡A
Substantial variability in community respiratory syncytial virus season timing
‡9
1
|
|
919
|
|
|
‡a
substancepreceptorexpressiononlymphocytesisassociatedwiththeimmuneresponsetorespiratorysyncytialvirusinfection
‡A
Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection
‡9
1
|
|
919
|
|
|
‡a
strategicprioritiesforrespiratorysyncytialvirusrsvvaccinedevelopment
‡A
Strategic priorities for respiratory syncytial virus (RSV) vaccine development
‡9
1
|
|
919
|
|
|
‡a
strategicprioritiesforrespiratorysyncytialvirus
‡A
Strategic priorities for respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
strainspecificreversetranscriptasepcrassaymeanstodistinguishcandidatevaccinefromwildtypestrainsofrespiratorysyncytialvirus
‡A
Strain-specific reverse transcriptase PCR assay: means to distinguish candidate vaccine from wild-type strains of respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
spectrophotometricquantitationofperoxidasestainedproteinbandsfollowinggelelectrophoresisandthewesternblottransfertechniquewithrespiratorysyncytialvirus
‡A
Spectrophotometric quantitation of peroxidase-stained protein bands following gel electrophoresis and the western blot transfer technique with respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
simultaneousdetectionandidentificationofhumanparainfluenzaviruses12and3fromclinicalsamplesbymultiplexpcr
‡A
Simultaneous detection and identification of human parainfluenza viruses 1, 2, and 3 from clinical samples by multiplex PCR
‡9
1
|
|
919
|
|
|
‡a
sexspecificassociationbetweenprenatallifestressexposureandinfantproinflammatorycytokinelevelsduringacuterespiratoryinfection
‡A
Sex-specific association between prenatal life stress exposure and infant pro-inflammatory cytokine levels during acute respiratory infection
‡9
1
|
|
919
|
|
|
‡a
severepostvacciniaencephalitiswithacutedisseminatedencephalomyelitisrecoverywithearlyintravenousimmunoglobulinhighdosesteroidsandvacciniaimmunoglobulin
‡A
Severe postvaccinia encephalitis with acute disseminated encephalomyelitis: recovery with early intravenous immunoglobulin, high-dose steroids, and vaccinia immunoglobulin
‡9
1
|
|
919
|
|
|
‡a
severebronchiolitisandrespiratorysyncytialvirusamongyoungchildreninhawaii
‡A
Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii
‡9
1
|
|
919
|
|
|
‡a
severeanemiacausedbyhumanparvovirusinaleukemiapatientonmaintenancechemotherapy
‡A
Severe anemia caused by human parvovirus in a leukemia patient on maintenance chemotherapy
‡9
1
|
|
919
|
|
|
‡a
severeacuterespiratorysyndromereviewandlessonsofthe2003outbreak
‡A
Severe acute respiratory syndrome: review and lessons of the 2003 outbreak
‡9
1
|
|
919
|
|
|
‡a
severeacuterespiratorysyndromeinchildren
‡A
Severe acute respiratory syndrome in children
‡9
1
|
|
919
|
|
|
‡a
severeacuterespiratorysyndromecoronavirusonhospitalsurfaces
‡A
Severe acute respiratory syndrome coronavirus on hospital surfaces
‡9
1
|
|
919
|
|
|
‡a
serumimmunoglobulingantibodysubclassresponsetorespiratorysyncytialvirusfandgglycoproteinsafter12and3infections
‡A
Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections
‡9
1
|
|
919
|
|
|
‡a
serumimmunoglobulinaresponsetonorwalkvirusinfection
‡A
Serum immunoglobulin A response to Norwalk virus infection
‡9
1
|
|
919
|
|
|
‡a
serologicevidenceofanassociationbetweenenterovirusesandtheonsetoftype1diabetesmellituspittsburghdiabetesresearchgroup
‡A
Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group
‡9
1
|
|
919
|
|
|
‡a
sequencepolymorphismofthepredictedhumanmetapneumovirusgglycoprotein
‡A
Sequence polymorphism of the predicted human metapneumovirus G glycoprotein
‡9
1
|
|
919
|
|
|
‡a
sequenceanalysisofthenp1000andfgenesofcanadianhumanmetapneumovirusstrains
‡A
Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains.
‡9
1
|
|
919
|
|
|
‡a
sensitiveandbroadlyreactivereversetranscriptionpcrassaystodetectnovelparamyxoviruses
‡A
Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses
‡9
1
|
|
919
|
|
|
‡a
secretoryexpressionandpurificationofrespiratorysyncytialvirusgandfproteinsinhumancells
‡A
Secretory Expression and Purification of Respiratory Syncytial Virus G and F Proteins in Human Cells
‡9
1
|
|
919
|
|
|
‡a
seasonaltrendsofhumanparainfluenzaviralinfectionsunitedstates1990
‡A
Seasonal trends of human parainfluenza viral infections: United States, 1990-2004.
‡9
1
|
|
919
|
|
|
‡a
seasonaltimingofinfantbronchiolitisapneaandsuddenunexplainedinfantdeath
‡A
Seasonal Timing of Infant Bronchiolitis, Apnea and Sudden Unexplained Infant Death
‡9
1
|
|
919
|
|
|
‡a
sarssurveillanceduringemergencypublichealthresponseunitedstatesmarchjuly
‡A
SARS surveillance during emergency public health response, United States, March-July 2003.
‡9
1
|
|
919
|
|
|
‡a
sarspreparednessandresponseplanning
‡A
SARS preparedness and response planning
‡9
1
|
|
919
|
|
|
‡a
sarscoronavirusreplicationinhumanperipheralmonocytesmacrophages
‡A
SARS-coronavirus replication in human peripheral monocytes/macrophages
‡9
1
|
|
919
|
|
|
‡a
sarsassociatedcoronavirustransmissionunitedstates
‡A
SARS-associated coronavirus transmission, United States
‡9
1
|
|
919
|
|
|
‡a
rsvstrainsanddiseaseseverity
‡A
RSV Strains and Disease Severity
‡9
1
|
|
919
|
|
|
‡a
rotavirusasacauseofdiarrhealmorbidityandmortalityintheunitedstates
‡A
Rotavirus as a cause of diarrheal morbidity and mortality in the United States
‡9
1
|
|
919
|
|
|
‡a
roleofparvovirusb19inhumandisease
‡A
Role of parvovirus B19 in human disease
‡9
1
|
|
919
|
|
|
‡a
riskofinfectionfollowingexposurestohumanparvovirusb19
‡A
Risk of infection following exposures to human parvovirus B19
‡9
1
|
|
919
|
|
|
‡a
riskofadverseoutcomesofpregnancyafterhumanparvovirusb19infection
‡A
Risk of adverse outcomes of pregnancy after human parvovirus B19 infection
‡9
1
|
|
919
|
|
|
‡a
riskfactorsfornipahvirusinfectionamongabattoirworkersinsingapore
‡A
Risk factors for Nipah virus infection among abattoir workers in Singapore
‡9
1
|
|
919
|
|
|
‡a
riskfactorsforbronchiolitisassociateddeathsamonginfantsintheunitedstates
‡A
Risk factors for bronchiolitis-associated deaths among infants in the United States
‡9
1
|
|
919
|
|
|
‡a
rhinovirusassociatedhospitalizationsinyoungchildren
‡A
Rhinovirus-associated hospitalizations in young children
‡9
1
|
|
919
|
|
|
‡a
responsetorhinovirusinfectionbyhumanairwayepithelialcellsandperipheralbloodmononuclearcellsinaninvitro2chambertissueculturesystem
‡A
Response to rhinovirus infection by human airway epithelial cells and peripheral blood mononuclear cells in an in vitro two-chamber tissue culture system
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialviruswholegenomesequencingidentifiesconvergentevolutionofsequenceduplicationinthe100terminusoftheggene
‡A
Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusvaccinesforotitismedia
‡A
Respiratory syncytial virus vaccines for otitis media
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusvaccinedevelopment
‡A
Respiratory syncytial virus vaccine development
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialviruspneumoniaamongtheelderlyanassessmentofdiseaseburden
‡A
Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusoutbreakonamericansamoaevaluationofriskfactors
‡A
Respiratory syncytial virus outbreak on American Samoa. Evaluation of risk factors
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusisanimportantcauseofcommunityacquiredlowerrespiratoryinfectionamonghospitalizedadults
‡A
Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusinfectionandgandorshproteinexpressioncontributetosubstancepwhichmediatesinflammationandenhancedpulmonarydiseaseinbalb100mice
‡A
Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirushospitalizationsamongamericanindianandalaskanativeinfantsandthegeneralunitedstatesinfantpopulation
‡A
Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusgproteincx3cmotifimpairshumanairwayepithelialandimmunecellresponses
‡A
Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusgproteinandgproteincx3cmotifadverselyaffectcx3cr1+tcellresponses
‡A
Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusgandorshproteinaltersth1cytokinesnaturalkillercellsandneutrophilsrespondingtopulmonaryinfectioninbalb100mice
‡A
Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice.
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusgandorshglycoproteinsmodify200and190chemokinemrnaexpressioninthebalb100mouse
‡A
Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusassociatedhospitalizationsamonginfantsandyoungchildrenintheunitedstates1997
‡A
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusandstaphylococcusaureuscoinfectioninchildrenhospitalizedwithpneumonia
‡A
Respiratory syncytial virus and Staphylococcus aureus coinfection in children hospitalized with pneumonia
‡9
1
|
|
919
|
|
|
‡a
respiratorysyncytialvirusactivatesinnateimmunitythroughtolllikereceptor2
‡A
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.
‡9
1
|
|
919
|
|
|
‡a
respiratorysynctialvirusinfectioninbalb100micepreviouslyimmunizedwithformalininactivatedvirusinducesenhancedpulmonaryinflammatoryresponsewithapredominantth2likecytokinepattern
‡A
Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern
‡9
1
|
|
919
|
|
|
‡a
refractorystatusepilepticusinsuspectencephalitis
‡A
Refractory status epilepticus in suspect encephalitis
‡9
1
|
|
919
|
|
|
‡a
recommendationsforusingsmallpoxvaccineinapreeventvaccinationprogramsupplementalrecommendationsoftheadvisorycommitteeonimmunizationpracticesacipandthehealthcareinfectioncontrolpracticesadvisorycommitteehicpac
‡A
Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
‡9
1
|
|
919
|
|
|
‡a
recombinantproteinbasedassaysfordetectionofantibodiestosevereacuterespiratorysyndromecoronavirusspikeandnucleocapsidproteins
‡A
Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins
‡9
1
|
|
919
|
|
|
‡a
realtimereversetranscriptionpolymerasechainreactionassayforsarsassociatedcoronavirus
‡A
Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus
‡9
1
|
|
919
|
|
|
‡a
realtimedetectionofvirusparticlesandviralproteinexpressionwith2colornanoparticleprobes
‡A
Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes.
‡9
1
|
|
919
|
|
|
‡a
rapidmolecularepidemiologicstudiesofhumanparainfluenzavirusesbasedondirectsequencingofamplifieddnafromamultiplexrtpcrassay
‡A
Rapid molecular epidemiologic studies of human parainfluenza viruses based on direct sequencing of amplified DNA from a multiplex RT-PCR assay
‡9
1
|
|
919
|
|
|
‡a
rapidantibodyresponsetohumandiploidrabiesvaccine
‡A
Rapid antibody response to human diploid rabies vaccine
‡9
1
|
|
919
|
|
|
‡a
rabiesdiagnosisandrabiesvaccine
‡A
Rabies diagnosis and rabies vaccine
‡9
1
|
|
919
|
|
|
‡a
quantificationofrespiratorysyncytialviruspolypeptidesinnasalsecretionsbymonoclonalantibodies
‡A
Quantification of respiratory syncytial virus polypeptides in nasal secretions by monoclonal antibodies
‡9
1
|
|
919
|
|
|
‡a
pulmonarydeliveryofrespiratorysyncytialvirusdnavaccinesusingmacroaggregatedalbuminparticles
‡A
Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles
‡9
1
|
|
919
|
|
|
‡a
protectiveroleofindoleamine23dioxygenaseinrespiratorysyncytialvirusassociatedimmuneresponseinairwayepithelialcells
‡A
Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells
‡9
1
|
|
919
|
|
|
‡a
protectiveanddiseaseenhancingimmuneresponsestorespiratorysyncytialvirus
‡A
Protective and disease-enhancing immune responses to respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
prophylaxiswitharespiratorysyncytialvirusrsvantigproteinmonoclonalantibodyshiftstheadaptiveimmuneresponsetorsvra2line19finfectionfromth2toth1inbalb100mice
‡A
Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice
‡9
1
|
|
919
|
|
|
‡a
prophylaxiswitharespiratorysyncytialvirus
‡A
Prophylaxis with a respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
prophylaxisforpersonsincontactwithpatientswhohaverabies
‡A
Prophylaxis for persons in contact with patients who have rabies
‡9
1
|
|
919
|
|
|
‡a
prophylactictreatmentwithagglycoproteinmonoclonalantibodyreducespulmonaryinflammationinrespiratorysyncytialvirusrsvchallengednaiveandformalininactivatedrsvimmunizedbalb100mice
‡A
Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice.
‡9
1
|
|
919
|
|
|
‡a
prophylactictreatmentwithagglycoproteinmonoclonalantibodyreducespulmonaryinflammationinrespiratorysyncytialvirus
‡A
Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
progressinvaccinepreventableandrespiratoryinfectiousdiseases110yearsofthecdcnationalcenterforimmunizationandrespiratorydiseases2006
‡A
Progress in Vaccine-Preventable and Respiratory Infectious Diseases-First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006-2015
‡9
1
|
|
919
|
|
|
‡a
priorairwayexposuretoallergenincreasesvirusinducedairwayhyperresponsiveness
‡A
Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness.
‡9
1
|
|
919
|
|
|
‡a
primingwithliverespiratorysyncytialvirusrsvpreventstheenhancedpulmonaryinflammatoryresponseseenafterrsvchallengeinbalb100miceimmunizedwithformalininactivatedrsv
‡A
Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV.
‡9
1
|
|
919
|
|
|
‡a
prevalenceofviralrespiratorytractinfectionsinchildrenwithasthma
‡A
Prevalence of viral respiratory tract infections in children with asthma.
‡9
1
|
|
919
|
|
|
‡a
prevalenceofhumanparvovirusb19infectioninchildrenwithhenochschonleinpurpura
‡A
Prevalence of human parvovirus B19 infection in children with Henoch-Schönlein purpura
‡9
1
|
|
919
|
|
|
‡a
prevalenceofantibodiestohumanparvovirusb19nonstructuralproteininpersonswithvariousclinicaloutcomesfollowingb19infection
‡A
Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection
‡9
1
|
|
919
|
|
|
‡a
prenataldiagnosisofintrauterineinfectionwithparvovirusb19bythepolymerasechainreactiontechnique
‡A
Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique
‡9
1
|
|
919
|
|
|
‡a
potentneutralizationofsevereacuterespiratorysyndromesarscoronavirusbyahumanmabtos1proteinthatblocksreceptorassociation
‡A
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
‡9
1
|
|
919
|
|
|
‡a
potenthighaffinityantibodiesfortreatmentandprophylaxisofrespiratorysyncytialvirusderivedfrombcellsofinfectedpatients
‡A
Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients.
‡9
1
|
|
919
|
|
|
‡a
potencyanalysisofmesenchymalstromalcellsusingacombinatorialassaymatrixapproach
‡A
Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.
‡9
1
|
|
919
|
|
|
‡a
postexposuretrialofahumandiploidcellstrainrabiesvaccine
‡A
Postexposure trial of a human diploid cell strain rabies vaccine.
‡9
1
|
|
919
|
|
|
‡a
possibletransmissionofparvovirusb19fromintravenousimmuneglobulin
‡A
Possible transmission of parvovirus B19 from intravenous immune globulin
‡9
1
|
|
919
|
|
|
‡a
populationbiologyevolutionandimmunologyofvaccinationandvaccinationprograms
‡A
Population biology, evolution, and immunology of vaccination and vaccination programs.
‡9
1
|
|
919
|
|
|
‡a
pharyngoconjunctivalfevercausedbyadenovirustype4reportofaswimmingpoolrelatedoutbreakwithrecoveryofvirusfrompoolwater
‡A
Pharyngoconjunctival Fever Caused by Adenovirus Type 4: Report of a Swimming Pool-Related Outbreak with Recovery of Virus from Pool Water
‡9
1
|
|
919
|
|
|
‡a
persistentparvovirusb19infectionwithoutthedevelopmentofchronicanemiainhivinfectedanduninfectedchildrenthewomenandinfantstransmissionstudy
‡A
Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study
‡9
1
|
|
919
|
|
|
‡a
peripheralbloodmononuclearcellsfrominfantshospitalizedbecauseofrespiratorysyncytialvirusinfectionexpressthelper1andthelper2cytokinesand200chemokinemessengerrna
‡A
Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA.
‡9
1
|
|
919
|
|
|
‡a
performanceevaluationofantibodytestsfordetectinginfantrespiratorysyncytialvirusinfection
‡A
Performance evaluation of antibody tests for detecting infant respiratory syncytial virus infection
‡9
1
|
|
919
|
|
|
‡a
pediatrichospitalizationsforcrouplaryngotracheobronchitisbiennialincreasesassociatedwithhumanparainfluenzavirus1epidemics
‡A
Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics
‡9
1
|
|
919
|
|
|
‡a
pediatrichospitalizationsforcroup
‡A
Pediatric hospitalizations for croup
‡9
1
|
|
919
|
|
|
‡a
patternrecognitionreceptorstlr4andcd14mediateresponsetorespiratorysyncytialvirus
‡A
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
pathologicstudiesoffatalcasesinoutbreakofhandfootandmouthdiseasetaiwan
‡A
Pathologic Studies of Fatal Cases in Outbreak of Hand, Foot, and Mouth Disease, Taiwan
‡9
1
|
|
919
|
|
|
‡a
parvovirusb19quiescenceduringthecourseofhumanimmunodeficiencyvirusinfectioninpersonswithhemophilia
‡A
Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophilia
‡9
1
|
|
919
|
|
|
‡a
parvovirusb19infectioninhospitalworkerscommunityorhospitalacquisition
‡A
Parvovirus B19 infection in hospital workers: community or hospital acquisition?
‡9
1
|
|
919
|
|
|
‡a
parainfluenzavirusinfectionamongadultshospitalizedforlowerrespiratorytractinfection
‡A
Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection
‡9
1
|
|
919
|
|
|
‡a
outpatientandhospitalvisitsassociatedwithotitismediaamongamericanindianandalaskanativechildrenyoungerthan5years
‡A
Outpatient and hospital visits associated with otitis media among American Indian and Alaska native children younger than 5 years
‡9
1
|
|
919
|
|
|
‡a
outbreakofsevererespiratorydiseaseassociatedwithemergenthumanadenovirusserotype14atausairforcetrainingfacilityin
‡A
Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007.
‡9
1
|
|
919
|
|
|
‡a
outbreakofpneumoniainalongtermcarefacilityantecedenthumanparainfluenzavirus1infectionmaypredisposetobacterialpneumonia
‡A
Outbreak of pneumonia in a long-term care facility: antecedent human parainfluenza virus 1 infection may predispose to bacterial pneumonia
‡9
1
|
|
919
|
|
|
‡a
outbreakofpneumoniaassociatedwithemergenthumanadenovirusserotype14southeastalaska
‡A
Outbreak of pneumonia associated with emergent human adenovirus serotype 14--Southeast Alaska, 2008
‡9
1
|
|
919
|
|
|
‡a
outbreakofechovirus11infectioninhospitalizedneonates
‡A
Outbreak of echovirus 11 infection in hospitalized neonates
‡9
1
|
|
919
|
|
|
‡a
occurrenceofgroupsaandbofrespiratorysyncytialvirusover15yearsassociatedepidemiologicandclinicalcharacteristicsinhospitalizedandambulatorychildren
‡A
Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children
‡9
1
|
|
919
|
|
|
‡a
occupationalriskofhumanparvovirusb19infectionforschoolanddaycarepersonnelduringanoutbreakoferythemainfectiosum
‡A
Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum
‡9
1
|
|
919
|
|
|
‡a
objectivesdesignandenrollmentresultsfromtheinfantsusceptibilitytopulmonaryinfectionsandasthmafollowingrsvexposurestudyinspire
‡A
Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE).
‡9
1
|
|
919
|
|
|
‡a
novelhumanrhinovirusesandexacerbationofasthmainchildren
‡A
Novel human rhinoviruses and exacerbation of asthma in children
‡9
1
|
|
919
|
|
|
‡a
nosocomialtransmissionofrespiratorysyncytialvirusinimmunocompromisedadults
‡A
Nosocomial transmission of respiratory syncytial virus in immunocompromised adults.
‡9
1
|
|
919
|
|
|
‡a
norwalkvirusantigenandantibodyresponseinanadultvolunteerstudy
‡A
Norwalk virus antigen and antibody response in an adult volunteer study
‡9
1
|
|
919
|
|
|
‡a
nonclassicmeaslesinfectionsinanimmunepopulationexposedtomeaslesduringacollegebustrip
‡A
Nonclassic measles infections in an immune population exposed to measles during a college bus trip
‡9
1
|
|
919
|
|
|
‡a
nipahvirusarecentlyemergentdeadlyparamyxovirus
‡A
Nipah virus: a recently emergent deadly paramyxovirus
‡9
1
|
|
919
|
|
|
‡a
neutralizingantifglycoproteinandantisubstancepantibodytreatmenteffectivelyreducesinfectionandinflammationassociatedwithrespiratorysyncytialvirusinfection
‡A
Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection
‡9
1
|
|
919
|
|
|
‡a
neutralizationofrespiratorysyncytialvirusbyindividualandmixturesoffandgproteinmonoclonalantibodies
‡A
Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies.
‡9
1
|
|
919
|
|
|
‡a
nationalsurveillanceofkawasakidisease
‡A
National surveillance of Kawasaki disease.
‡9
1
|
|
919
|
|
|
‡a
nationalsurveillanceforrespiratorysyncytialvirusunitedstates1985
‡A
National surveillance for respiratory syncytial virus, United States, 1985-1990.
‡9
1
|
|
919
|
|
|
‡a
nasopharyngealmicrobiomeinrespiratorysyncytialvirusresemblesprofileassociatedwithincreasedchildhoodasthmarisk
‡A
Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk
‡9
1
|
|
919
|
|
|
‡a
nasopharyngeallactobacillusisassociatedwithchildhoodwheezingillnessesfollowingacuterespiratorysyncytialvirusinfectionininfancy
‡A
Nasopharyngeal Lactobacillus is Associated with Childhood Wheezing Illnesses Following Acute Respiratory Syncytial Virus Infection in Infancy
‡9
1
|
|
919
|
|
|
‡a
nasopharyngealhaemophilusandlocalimmuneresponseduringinfantrespiratorysyncytialvirusinfection
‡A
Nasopharyngeal Haemophilus and Local Immune Response during Infant Respiratory Syncytial Virus Infection
‡9
1
|
|
919
|
|
|
‡a
nanoparticlevaccinesencompassingtherespiratorysyncytialvirusrsvgproteincx3cchemokinemotifinducerobustimmunityprotectingfromchallengeanddisease
‡A
Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease
‡9
1
|
|
919
|
|
|
‡a
nanoparticlevaccinesencompassingtherespiratorysyncytialvirus
‡A
Nanoparticle vaccines encompassing the respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
mutationofrespiratorysyncytialvirusgproteinscx3cmotifattenuatesinfectionincottonratsandprimaryhumanairwayepithelialcells
‡A
Mutation of Respiratory Syncytial Virus G Protein's CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells
‡9
1
|
|
919
|
|
|
‡a
mutatingthecx3cmotifinthegproteinshouldmakealiverespiratorysyncytialvirusvaccinesaferandmoreeffective
‡A
Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective
‡9
1
|
|
919
|
|
|
‡a
multiplexassayfordetectionofstrainspecificantibodiesagainstthe2variableregionsofthegproteinofrespiratorysyncytialvirus
‡A
Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
multiple1pairsforpolymerasechainreactionpcramplificationofhumanparvovirusb19dna
‡A
Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA
‡9
1
|
|
919
|
|
|
‡a
multiple1pairsforpolymerasechainreaction
‡A
Multiple primer pairs for polymerase chain reaction
‡9
1
|
|
919
|
|
|
‡a
multicenterstudyofstrainsofrespiratorysyncytialvirus
‡A
Multicenter study of strains of respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
muc5aclevelsassociatedwithrespiratorysyncytialvirusdiseaseseverity
‡A
MUC5AC Levels Associated With Respiratory Syncytial Virus Disease Severity
‡9
1
|
|
919
|
|
|
‡a
mortalityassociatedwithinfluenzaandrespiratorysyncytialvirusintheunitedstates
‡A
Mortality associated with influenza and respiratory syncytial virus in the United States
‡9
1
|
|
919
|
|
|
‡a
monoclonalcaptureantibodyelisaforrespiratorysyncytialvirusdetectionofindividualviralantigensanddeterminationofmonoclonalantibodyspecificities
‡A
Monoclonal capture antibody ELISA for respiratory syncytial virus: detection of individual viral antigens and determination of monoclonal antibody specificities
‡9
1
|
|
919
|
|
|
‡a
monoclonalantibodybasedcaptureenzymeimmunoassaysforspecificserumimmunoglobulingiggigaandigmantibodiestorespiratorysyncytialvirus
‡A
Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
monoclonalantibodiestosarsassociatedcoronavirussarscovidentificationofneutralizingandantibodiesreactivetosn1000andeviralproteins
‡A
Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins
‡9
1
|
|
919
|
|
|
‡a
monoclonalantibodiesfortherapiddiagnosisofrespiratorysyncytialvirusinfectionbyimmunofluorescence
‡A
Monoclonal antibodies for the rapid diagnosis of respiratory syncytial virus infection by immunofluorescence
‡9
1
|
|
919
|
|
|
‡a
molecularepidemiologyofadenovirustype7intheunitedstates1966
‡A
Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000
‡9
1
|
|
919
|
|
|
‡a
moleculardetectionofadenovirusesrhabdovirusesandparamyxovirusesinbatsfromkenya
‡A
Molecular detection of adenoviruses, rhabdoviruses, and paramyxoviruses in bats from Kenya
‡9
1
|
|
919
|
|
|
‡a
molecularcharacterizationofnipahvirusanewlyemergentparamyxovirus
‡A
Molecular characterization of Nipah virus, a newly emergent paramyxovirus
‡9
1
|
|
919
|
|
|
‡a
molecularcharacterizationofanosocomialoutbreakofhumanrespiratorysyncytialvirusonanadultleukemialymphomaward
‡A
Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward
‡9
1
|
|
919
|
|
|
‡a
minimallyinvasivesamplingmethodidentifiesdifferencesintaxonomicrichnessofnasalmicrobiomesinyounginfantsassociatedwithmodeofdelivery
‡A
Minimally Invasive Sampling Method Identifies Differences in Taxonomic Richness of Nasal Microbiomes in Young Infants Associated with Mode of Delivery.
‡9
1
|
|
919
|
|
|
‡a
microneutralizationtestforrespiratorysyncytialvirusbasedonanenzymeimmunoassay
‡A
Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay
‡9
1
|
|
919
|
|
|
‡a
managementandoutcomesofpregnanciescomplicatedbyhumanb19parvovirusinfectionaprospectivestudy
‡A
Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study
‡9
1
|
|
919
|
|
|
‡a
lowerrespiratorytractinfectionsamongamericanindianandalaskanativechildrenandthegeneralpopulationofuschildren
‡A
Lower respiratory tract infections among american Indian and Alaska Native children and the general population of U.S. Children
‡9
1
|
|
919
|
|
|
‡a
laboratorydiagnosisof4recentsporadiccasesofcommunityacquiredsarsguangdongprovincechina
‡A
Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China
‡9
1
|
|
919
|
|
|
‡a
kawasakisyndromedescriptionof2outbreaksintheunitedstates
‡A
Kawasaki Syndrome: Description of Two Outbreaks in the United States
‡9
1
|
|
919
|
|
|
‡a
kawasakidiseaseinayoungadult
‡A
Kawasaki disease in a young adult
‡9
1
|
|
919
|
|
|
‡a
kawasakidiseaseandhumancoronavirus
‡A
Kawasaki disease and human coronavirus
‡9
1
|
|
919
|
|
|
‡a
involvementoftolllikereceptor4ininnateimmunitytorespiratorysyncytialvirus
‡A
Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
investigationofporcineparvovirusamongpersonswithhemophiliareceivinghyate100porcinefactor8concentrate
‡A
Investigation of porcine parvovirus among persons with hemophilia receiving Hyate:C porcine factor VIII concentrate
‡9
1
|
|
919
|
|
|
‡a
interferencebetweenrespiratorysyncytialvirusandhumanrhinovirusinfectionininfancy
‡A
Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy.
‡9
1
|
|
919
|
|
|
‡a
infectiousdiseasehospitalizationsamongamericanindianandalaskanativeinfants
‡A
Infectious disease hospitalizations among American Indian and Alaska native infants
‡9
1
|
|
919
|
|
|
‡a
infantviralrespiratoryinfectionnasalimmuneresponsepatternsandtheirassociationwithsubsequentchildhoodrecurrentwheeze
‡A
Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze
‡9
1
|
|
919
|
|
|
‡a
inductionofcytokinemrnainperipheralbloodmononuclearcellsofinfantsafterthe1doseofmeaslesvaccine
‡A
Induction of cytokine mRNA in peripheral blood mononuclear cells of infants after the first dose of measles vaccine
‡9
1
|
|
919
|
|
|
‡a
invitromodelfortheassessmentofhumanimmuneresponsestosubunitrsvvaccines
‡A
In vitro model for the assessment of human immune responses to subunit RSV vaccines
‡9
1
|
|
919
|
|
|
‡a
insearchofencephalitisetiologiesdiagnosticchallengesinthecaliforniaencephalitisproject1998
‡A
In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000.
‡9
1
|
|
919
|
|
|
‡a
immunochemiluminescentsouthernblotassayforpolymerasechainreactiondetectionofhumanparvovirusb19dna
‡A
Immunochemiluminescent Southern blot assay for polymerase chain reaction detection of human parvovirus B19 DNA
‡9
1
|
|
919
|
|
|
‡a
immunedysfunctionalityofreplicativesenescentmesenchymalstromalcellsiscorrectedbyifnγpriming
‡A
Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming
‡9
1
|
|
919
|
|
|
‡a
identifyinggapsinrespiratorysyncytialvirusdiseaseepidemiologyintheunitedstatespriortotheintroductionofvaccines
‡A
Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines
‡9
1
|
|
919
|
|
|
‡a
identificationofthemajorstructuralandnonstructuralproteinsencodedbyhumanparvovirusb19andmappingoftheirgenesbyprocaryoticexpressionofisolatedgenomicfragments
‡A
Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments
‡9
1
|
|
919
|
|
|
‡a
identificationofepitopesonrespiratorysyncytialvirusproteinsbycompetitivebindingimmunoassay
‡A
Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay
‡9
1
|
|
919
|
|
|
‡a
identificationofadenovirusesinfecalspecimensfromwildchimpanzeespantrogylodytesschweinfurthiiinwesterntanzania
‡A
Identification of adenoviruses in fecal specimens from wild chimpanzees (Pan trogylodytes schweinfurthii) in western Tanzania
‡9
1
|
|
919
|
|
|
‡a
identificationofanovelastrovirusastrovirusva1associatedwithanoutbreakofacutegastroenteritis
‡A
Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis
‡9
1
|
|
919
|
|
|
‡a
identificationofanovelastrovirus
‡A
Identification of a novel astrovirus
‡9
1
|
|
919
|
|
|
‡a
humantohumantransmissionofrabiesvirusbycornealtransplant
‡A
Human-to-Human Transmission of Rabies Virus by Corneal Transplant
‡9
1
|
|
919
|
|
|
‡a
humanrhinovirusspeciesassociatedwithhospitalizationsforacuterespiratoryillnessinyounguschildren
‡A
Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children
‡9
1
|
|
919
|
|
|
‡a
humanrhinovirusinducedcytokinechemokineresponsesinhumanairwayepithelialandimmunecells
‡A
Human rhinovirus induced cytokine/chemokine responses in human airway epithelial and immune cells
‡9
1
|
|
919
|
|
|
‡a
humanrabiesintheunitedstates1960to1979epidemiologydiagnosisandprevention
‡A
Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention
‡9
1
|
|
919
|
|
|
‡a
humanparvoviruses
‡A
Human parvoviruses
‡9
1
|
|
919
|
|
|
‡a
humanparvovirusb19specificiggigaandigmantibodiesanddnainserumspecimensfrompersonswitherythemainfectiosum
‡A
Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum
‡9
1
|
|
919
|
|
|
‡a
humanparvovirusb19infectionduringpregnancy
‡A
Human parvovirus B19 infection during pregnancy
‡9
1
|
|
919
|
|
|
‡a
humanparvovirusb19inducedepidemicacuteredcellaplasiainpatientswithhereditaryhemolyticanemia
‡A
Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia
‡9
1
|
|
919
|
|
|
‡a
humanparvovirusb19andpregnancy
‡A
Human parvovirus B19 and pregnancy.
‡9
1
|
|
919
|
|
|
‡a
humanparvovirusb19
‡A
Human parvovirus B19
‡9
1
|
|
919
|
|
|
‡a
humanparainfluenzavirusassociatedhospitalizationsamongchildrenlessthan5yearsofageintheunitedstates
‡A
Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States
‡9
1
|
|
919
|
|
|
‡a
humanmetapneumovirusinfectionsinyoungandelderlyadults
‡A
Human metapneumovirus infections in young and elderly adults.
‡9
1
|
|
919
|
|
|
‡a
humanmetapneumovirusinfectionamongchildrenhospitalizedwithacuterespiratoryillness
‡A
Human metapneumovirus infection among children hospitalized with acute respiratory illness
‡9
1
|
|
919
|
|
|
‡a
humanbocavirusanovelparvovirusepidemiologicallyassociatedwithpneumoniarequiringhospitalizationinthailand
‡A
Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand
‡9
1
|
|
919
|
|
|
‡a
humanbocavirusanewviralpathogen
‡A
Human bocavirus: a new viral pathogen
‡9
1
|
|
919
|
|
|
‡a
hospitalizationsassociatedwithinfluenzaandrespiratorysyncytialvirusintheunitedstates1993
‡A
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.
‡9
1
|
|
919
|
|
|
‡a
healthcaretransmissionofanewlyemergentadenovirusserotypeinhealthcarepersonnelatamilitaryhospitalintexas
‡A
Health care transmission of a newly emergent adenovirus serotype in health care personnel at a military hospital in Texas, 2007.
‡9
1
|
|
919
|
|
|
‡a
guidelinesforpreventinghealthcareassociatedpneumonia2003recommendationsofcdcandthehealthcareinfectioncontrolpracticesadvisorycommittee
‡A
Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.
‡9
1
|
|
919
|
|
|
‡a
groupspecificserumantibodyresponsesinchildrenwithprimaryandrecurrentrespiratorysyncytialvirusinfections
‡A
Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections
‡9
1
|
|
919
|
|
|
‡a
genomiccharacterizationof7distinctbatcoronavirusesinkenya
‡A
Genomic characterization of seven distinct bat coronaviruses in Kenya
‡9
1
|
|
919
|
|
|
‡a
geneticvariabilityofgroupaandbhumanrespiratorysyncytialvirusesisolatedfrom3provincesinchina
‡A
Genetic variability of group A and B human respiratory syncytial viruses isolated from 3 provinces in China
‡9
1
|
|
919
|
|
|
‡a
geneticvariabilityinenvelopeassociatedproteingenesofcloselyrelatedgroupastrainsofrespiratorysyncytialvirus
‡A
Genetic variability in envelope-associated protein genes of closely related group A strains of respiratory syncytial virus
‡9
1
|
|
919
|
|
|
‡a
geneticheterogeneityoftheattachmentglycoproteingamonggrouparespiratorysyncytialviruses
‡A
Genetic heterogeneity of the attachment glycoprotein G among group A respiratory syncytial viruses
‡9
1
|
|
919
|
|
|
‡a
geneticdiversityoftheattachmentproteinofsubgroupbrespiratorysyncytialviruses
‡A
Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses
‡9
1
|
|
919
|
|
|
‡a
geneticdiversityofhumanparvovirusb19sequenceanalysisofthevp1vp2genefrommultipleisolates
‡A
Genetic diversity of human parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates
‡9
1
|
|
919
|
|
|
‡a
genescanreversetranscriptionpcrassayfordetectionof6commonrespiratoryvirusesinyoungchildrenhospitalizedwithacuterespiratoryillness
‡A
GeneScan reverse transcription-PCR assay for detection of six common respiratory viruses in young children hospitalized with acute respiratory illness
‡9
1
|
|
919
|
|
|
‡a
foundationsofthesevereacuterespiratorysyndromepreparednessandresponseplanforhealthcarefacilities
‡A
Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities
‡9
1
|
|
919
|
|
|
‡a
evaluationofthecalu3celllineasamodelofinvitrorespiratorysyncytialvirusinfection
‡A
Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infection
‡9
1
|
|
919
|
|
|
‡a
evaluationofmonoclonalantibodybasedcaptureenzymeimmunoassaysfordetectionofspecificantibodiestomeaslesvirus
‡A
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus.
‡9
1
|
|
919
|
|
|
‡a
epidemiologyandpreventionofrespiratorysyncytialvirusinfectionsamonginfantsandyoungchildren
‡A
Epidemiology and prevention of respiratory syncytial virus infections among infants and young children
‡9
1
|
|
919
|
|
|
‡a
epidemicinfectionscausedbyrespiratorysyncytialvirusininstitutionalizedyoungadults
‡A
Epidemic infections caused by respiratory syncytial virus in institutionalized young adults
‡9
1
|
|
919
|
|
|
‡a
enterovirusassociatedencephalitisinthecaliforniaencephalitisproject1998
‡A
Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005.
‡9
1
|
|
919
|
|
|
‡a
enterovirus71infectionsandneurologicdiseaseunitedstates1977
‡A
Enterovirus 71 infections and neurologic disease--United States, 1977-1991
‡9
1
|
|
919
|
|
|
‡a
enhanceddiseaseandpulmonaryeosinophiliaassociatedwithformalininactivatedrespiratorysyncytialvirusvaccinationarelinkedtogglycoproteincx3ccx3cr1interactionandexpressionofsubstancep
‡A
Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P
‡9
1
|
|
919
|
|
|
‡a
emerginghumancoronavirusesdiseasepotentialandpreparedness
‡A
Emerging human coronaviruses--disease potential and preparedness
‡9
1
|
|
919
|
|
|
‡a
18yearsofrespiratorysyncytialvirussurveillancechangesinseasonalityandhospitalizationratesinsouthwesternalaskanativechildren
‡A
Eighteen Years of Respiratory Syncytial Virus Surveillance: Changes in Seasonality and Hospitalization Rates in Southwestern Alaska Native Children.
‡9
1
|
|
919
|
|
|
‡a
echovirus30infectionandasepticmeningitisinparentsofchildrenattendingachildcarecenter
‡A
Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center.
‡9
1
|
|
919
|
|
|
‡a
directsequencingofsarscoronavirussandngenesfromclinicalspecimensshowslimitedvariation
‡A
Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation
‡9
1
|
|
919
|
|
|
‡a
differentiationofrespiratorysyncytialvirussubgroupswithcdnaprobesinanucleicacidhybridizationassay
‡A
Differentiation of respiratory syncytial virus subgroups with cDNA probes in a nucleic acid hybridization assay
‡9
1
|
|
919
|
|
|
‡a
differencesinthenasopharyngealmicrobiomeduringacuterespiratorytractinfectionwithhumanrhinovirusandrespiratorysyncytialvirusininfancy
‡A
Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy
‡9
1
|
|
919
|
|
|
‡a
diarrhealillnessamonginfantsandtoddlersindaycarecenterseffectsofactivesurveillanceandstafftrainingwithoutsubsequentmonitoring
‡A
Diarrheal illness among infants and toddlers in day care centers: effects of active surveillance and staff training without subsequent monitoring
‡9
1
|
|
919
|
|
|
‡a
diarrhealdeathsinamericanchildrenaretheypreventable
‡A
Diarrheal deaths in American children. Are they preventable?
‡9
1
|
|
919
|
|
|
‡a
diagnosisofmeasleswithanigmcaptureeiatheoptimaltimingofspecimencollectionafterrashonset
‡A
Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset
‡9
1
|
|
919
|
|
|
‡a
diagnosisofenterovirus70infectionbydemonstrationofigmantibodies
‡A
Diagnosis of enterovirus 70 infection by demonstration of IgM antibodies
‡9
1
|
|
919
|
|
|
‡a
developmentofarecombinanttruncatednucleocapsidproteinbasedimmunoassayfordetectionofantibodiesagainsthumancoronavirusoc43
‡A
Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43
‡9
1
|
|
919
|
|
|
‡a
developmentandoptimizationofazikavirusantibodydependentcellmediatedcytotoxicityadccassay
‡A
Development and optimization of a Zika virus antibody-dependent cell-mediated cytotoxicity (ADCC) assay
‡9
1
|
|
919
|
|
|
‡a
developmentandevaluationofanigmcaptureenzymeimmunoassayfordiagnosisofrecentnorwalkvirusinfection
‡A
Development and evaluation of an IgM capture enzyme immunoassay for diagnosis of recent Norwalk virus infection
‡9
1
|
|
919
|
|
|
‡a
detectionofrsvantibodiesinhumanplasmabyenzymeimmunoassays
‡A
Detection of RSV Antibodies in Human Plasma by Enzyme Immunoassays
‡9
1
|
|
919
|
|
|
‡a
detectionofnovelsarslikeandothercoronavirusesinbatsfromkenya
‡A
Detection of novel SARS-like and other coronaviruses in bats from Kenya
‡9
1
|
|
919
|
|
|
‡a
detectionofnorwalkvirusantibodiesandantigenwithabiotinavidinimmunoassay
‡A
Detection of Norwalk virus antibodies and antigen with a biotin-avidin immunoassay
‡9
1
|
|
919
|
|
|
‡a
detectionofenterovirus70withmonoclonalantibodies
‡A
Detection of enterovirus 70 with monoclonal antibodies
‡9
1
|
|
919
|
|
|
‡a
detectionofantibodiesandantigensofhumanparvovirusb19byenzymelinkedimmunosorbentassay
‡A
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay
‡9
1
|
|
919
|
|
|
‡a
decreaseinformalininactivatedrespiratorysyncytialvirusfirsvenhanceddiseasewithrsvgglycoproteinpeptideimmunizationinbalb100mice
‡A
Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice
‡9
1
|
|
919
|
|
|
‡a
deathsofchildrenduringanoutbreakofhandfootandmouthdiseaseinsarawakmalaysiaclinicalandpathologicalcharacteristicsofthediseasefortheoutbreakstudygroup
‡A
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group
‡9
1
|
|
919
|
|
|
‡a
daycarecenterattendanceandhospitalizationforlowerrespiratorytractillness
‡A
Day-care center attendance and hospitalization for lower respiratory tract illness
‡9
1
|
|
919
|
|
|
‡a
cytotoxictlymphocyteprecursorfrequenciesinbalb100miceafteracuterespiratorysyncytialvirusrsvinfectionorimmunizationwithaformalininactivatedrsvvaccine
‡A
Cytotoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin-inactivated RSV vaccine
‡9
1
|
|
919
|
|
|
‡a
cytokineresponsetorespiratorysyncytialvirusstimulationofhumanperipheralbloodmononuclearcells
‡A
Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells
‡9
1
|
|
919
|
|
|
‡a
cx3cr1isanimportantsurfacemoleculeforrespiratorysyncytialvirusinfectioninhumanairwayepithelialcells
‡A
CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.
‡9
1
|
|
919
|
|
|
‡a
cx3cchemokinemimicrybyrespiratorysyncytialvirusgglycoprotein
‡A
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
‡9
1
|
|
919
|
|
|
‡a
crosshostevolutionofsevereacuterespiratorysyndromecoronavirusinpalmcivetandhuman
‡A
Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human
‡9
1
|
|
919
|
|
|
‡a
coxsackievirusb2infectionandasepticmeningitisafocaloutbreakamongmembersofahighschoolfootballteam
‡A
Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team
‡9
1
|
|
919
|
|
|
‡a
coronavirusantibodiesinbatbiologists
‡A
Coronavirus antibodies in bat biologists
‡9
1
|
|
943
|
|
|
‡a
199x
‡A
1999
‡9
7
|
|
943
|
|
|
‡a
200x
‡A
2002
‡9
12
|
|
943
|
|
|
‡a
198x
‡A
1983
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2015
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
SUDOC|153810181
|
|
996
|
|
|
‡2
LC|n 98801274
|
|
996
|
|
|
‡2
SUDOC|15757122X
|
|
996
|
|
|
‡2
ISNI|0000000029360449
|
|
996
|
|
|
‡2
RERO|A011638654
|
|
996
|
|
|
‡2
CAOONL|ncf10196866
|
|
996
|
|
|
‡2
LC|no2008186341
|
|
996
|
|
|
‡2
RERO|A002928380
|
|
996
|
|
|
‡2
LC|no 98036950
|
|
996
|
|
|
‡2
NII|DA10589036
|
|
996
|
|
|
‡2
RERO|A024456242
|
|
996
|
|
|
‡2
SUDOC|260544663
|
|
996
|
|
|
‡2
LC|n 79088953
|
|
996
|
|
|
‡2
CAOONL|ncf10125682
|
|
996
|
|
|
‡2
CAOONL|ncf11426922
|
|
996
|
|
|
‡2
LC|n 2001017416
|
|
996
|
|
|
‡2
PLWABN|9810629462705606
|
|
996
|
|
|
‡2
LC|n 85804786
|
|
996
|
|
|
‡2
J9U|987007453564205171
|
|
996
|
|
|
‡2
ISNI|0000000500621699
|
|
996
|
|
|
‡2
J9U|987007413427005171
|
|
996
|
|
|
‡2
LC|no2017039238
|
|
996
|
|
|
‡2
J9U|987007342063405171
|
|
996
|
|
|
‡2
DBC|87097990066277
|
|
996
|
|
|
‡2
ISNI|0000000084544312
|
|
996
|
|
|
‡2
LC|n 80121569
|
|
996
|
|
|
‡2
ISNI|0000000047256821
|
|
996
|
|
|
‡2
LC|n 2008028212
|
|
996
|
|
|
‡2
BNCHL|10000000000000000146642
|
|
996
|
|
|
‡2
BIBSYS|99044584
|
|
996
|
|
|
‡2
ISNI|0000000073949613
|
|
996
|
|
|
‡2
LIH|LNB:CC2_k_;=BJ
|
|
996
|
|
|
‡2
CAOONL|ncf13717403
|
|
996
|
|
|
‡2
DNB|1104393549
|
|
996
|
|
|
‡2
CAOONL|ncf10249346
|
|
996
|
|
|
‡2
LC|n 80094466
|
|
996
|
|
|
‡2
LC|no2015092288
|
|
996
|
|
|
‡2
LC|n 89663272
|
|
996
|
|
|
‡2
LC|nr 89014577
|
|
996
|
|
|
‡2
ISNI|0000000036642399
|
|
996
|
|
|
‡2
ISNI|0000000394309668
|
|
996
|
|
|
‡2
SUDOC|061783153
|
|
996
|
|
|
‡2
BIBSYS|90112967
|
|
996
|
|
|
‡2
ISNI|0000000048364517
|
|
996
|
|
|
‡2
LC|no 92017963
|
|
996
|
|
|
‡2
BIBSYS|3099171
|
|
996
|
|
|
‡2
NUKAT|n 2015169742
|
|
996
|
|
|
‡2
ISNI|0000000366211663
|
|
996
|
|
|
‡2
ISNI|0000000021553879
|
|
996
|
|
|
‡2
LC|no2014016383
|
|
996
|
|
|
‡2
SUDOC|255419112
|
|
996
|
|
|
‡2
BIBSYS|90298422
|
|
996
|
|
|
‡2
ISNI|0000000077674418
|
|
996
|
|
|
‡2
CAOONL|ncf10976917
|
|
996
|
|
|
‡2
SUDOC|165931523
|
|
996
|
|
|
‡2
BNF|14592974
|
|
996
|
|
|
‡2
J9U|987007355654305171
|
|
996
|
|
|
‡2
LC|n 84047160
|
|
996
|
|
|
‡2
SUDOC|168721902
|
|
996
|
|
|
‡2
BIBSYS|90784260
|
|
996
|
|
|
‡2
ISNI|0000000408441345
|
|
996
|
|
|
‡2
W2Z|11018288
|
|
996
|
|
|
‡2
ISNI|0000000043352170
|
|
996
|
|
|
‡2
CAOONL|ncf11300401
|
|
996
|
|
|
‡2
LC|no2007117779
|
|
996
|
|
|
‡2
LC|n 85810092
|
|
996
|
|
|
‡2
SUDOC|153442999
|
|
996
|
|
|
‡2
NII|DA06310361
|
|
996
|
|
|
‡2
BIBSYS|90752224
|
|
996
|
|
|
‡2
NTA|068907508
|
|
996
|
|
|
‡2
NUKAT|n 2017181844
|
|
996
|
|
|
‡2
LC|n 88635866
|
|
996
|
|
|
‡2
ISNI|0000000033520927
|
|
996
|
|
|
‡2
LC|n 2016054541
|
|
996
|
|
|
‡2
LC|nb2010005812
|
|
996
|
|
|
‡2
ISNI|0000000034207377
|
|
996
|
|
|
‡2
ISNI|0000000037833082
|
|
996
|
|
|
‡2
LC|n 2001008796
|
|
996
|
|
|
‡2
DNB|134314719
|
|
996
|
|
|
‡2
LC|no2008014877
|
|
996
|
|
|
‡2
LC|n 88609272
|
|
996
|
|
|
‡2
LC|n 89625392
|
|
996
|
|
|
‡2
J9U|987007440798105171
|
|
996
|
|
|
‡2
BNF|12275773
|
|
996
|
|
|
‡2
RERO|A002928376
|
|
996
|
|
|
‡2
RERO|A002928377
|
|
996
|
|
|
‡2
LC|no2024101969
|
|
996
|
|
|
‡2
LC|no2019110459
|
|
996
|
|
|
‡2
BIBSYS|11018288
|
|
996
|
|
|
‡2
LC|nr2001000131
|
|
996
|
|
|
‡2
LC|n 89648631
|
|
996
|
|
|
‡2
LC|n 94009341
|
|
996
|
|
|
‡2
BNC|981060950364706706
|
|
997
|
|
|
‡a
1947 0 lived 0729 0
‡9
1
|
|
998
|
|
|
‡a
Anderson, L.J.
‡2
ISNI|0000000036642399
‡3
suggested
|
|
998
|
|
|
‡a
Anderson, Larry J.
‡2
ISNI|0000000036642399
‡3
suggested
|
|
998
|
|
|
‡a
Anderson, Larry J.
‡2
J9U|987007352794705171
‡3
suggested
‡3
exact title: (1.00, 'humanparvovirusb19', 'humanparvovirusb19')
|
|
998
|
|
|
‡a
Anderson, L.J.
‡q
(Larry J.)
‡2
NTA|168422417
‡3
suggested
|
|
998
|
|
|
‡a
Anderson, Larry J.
‡2
NUKAT|n 2017087522
‡3
suggested
‡3
viafid
‡3
exact title: (1.00, 'humanparvovirusb19', 'humanparvovirusb19')
|
|
998
|
|
|
‡a
Anderson, Larry J.
‡2
LC|n 96803379
‡3
suggested
‡3
exact title: (1.00, 'humanparvovirusb19', 'humanparvovirusb19')
|
|
998
|
|
|
‡a
Anderson, Larry J.
‡2
SUDOC|035007524
‡3
suggested
‡3
exact title: (1.00, 'humanparvovirusb19', 'humanparvovirusb19')
|
|
998
|
|
|
‡a
Anderson, Larry J.
‡2
NII|DA10662566
‡3
suggested
‡3
exact title: (1.00, 'humanparvovirusb19', 'humanparvovirusb19')
|
|
998
|
|
|
‡a
Anderson
‡b
Larry J.
‡2
BNF|12569728
‡3
suggested
‡3
exact title: (1.00, 'humanparvovirusb19', 'humanparvovirusb19')
|
